Clinical Trials
4 trialsNCT07555210 2026-05-06
Pilot Study of Bone Mineral Density Changes During Anti-PD-1 Immunotherapy
Vanderbilt-Ingram Cancer Center
Phase NA Recruiting
NCT04851119 2026-05-05
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Children's Oncology Group
Phase 1/2 Recruiting
NCT04516122 2025-08-17
Bone Loss in Melanoma Survivors Receiving Immunotherapy
M.D. Anderson Cancer Center
Terminated
NCT02352623 2016-05-26
Quality of Life and Surgical Late Effects of Melanoma Treatment
Herlev Hospital
Completed